Top Abstracts with Expert Perspective: Acute Leukaemias and Transplantation
Tracks
-
| Tuesday, April 29, 2025 |
| 8:30 AM - 10:00 AM |
| BSH Stage (Hall 4) |
Speaker
Dr Madonna M. Eltoukhy
Phd Student
University of Glasgow
CD180: A Novel Immune Marker and Target of Chemoresistance and Relapse in KMT2A-rerranged Paediatric AML.
8:30 AM - 8:45 AM
Dr Emma Searle
Consultant Haematologist and Honorary Senior Lecturer
The Christie NHS Foundation Trust and University of Manchester
Bleximenib Dose Optimization and RP2D Determination: Phase 1 Study in R/R AL with KMT2A/NPM1 Alterations
8:45 AM - 9:00 AM
Dr Deborah Yallop
Consultant Haematologist
King’s College Hospital NHS Foundation Trust
Tumour Burden-Guided Dosing in the FELIX Study of Obecabtagene autoleucel in Adult R/R B-ALL
9:00 AM - 9:15 AM
Dr Sandra M. Martin-Guerrero
Postdoctoral Research Assistant
Barts Cancer Institute, Queen Mary University Of London
Exploiting targeted inhibition of MASTL kinase in Acute Myeloid Leukaemia
9:15 AM - 9:30 AM
Dr Rachit Agrawal
Senior Resident
AIIMS New Delhi
The role of addition of bortezomib to standard multiagent induction chemotherapy in ALL patients
9:30 AM - 9:45 AM
Zhengyi Jia
Student
Xinjiang Medical University
Eltrombopag Targets Copper Metabolism and MAPK Pathway: A Novel Strategy for Acute Myeloid Leukemia Therapy
9:45 AM - 10:00 AMChair
Adele Fielding
Professor Of Haematology
University of York
